biosimilars and interchangeables - regulatory highlights (27of33) quality – oct. 16-17, 2019
Published 4 years ago • 307 plays • Length 14:31Download video MP4
Download video MP3
Similar videos
-
42:43
regulatory highlights for biosimilars and interchangeables (9of15) redi – may 29-30, 2019
-
16:06
data quality expectations for biosimilars with case studies (29of33) quality – oct. 16-17, 2019
-
2:03
biosimilars interchangeability
-
3:12
biosimilars: critical quality attributes
-
1:36
interchangeable biosimilars
-
2:47
biosimilars: approval process
-
24:48
fda perspectives on biosimilar bla-manufacturing (28of33) quality – oct. 16-17, 2019
-
1:42
biosimilars vs. interchangeable biosimilars: what’s the difference?
-
6:32
biosimilars: totality of the evidence in biosimilar development
-
4:12
the basics of biosimilars
-
4:41
2017 fda guidance on biosimilars
-
4:39
biosimilars: comparative analytical assessment
-
22:48
navigating the world of biosimilar user fees- june 10, 2019
-
3:33
biosimilars: manufacturing and inherent variation
-
3:07
the promise of biosimilars
-
6:00
quick guide to biosimilars
-
1:44
fast facts about the regulatory approval pathway for biosimilars – amgen science
-
1:50
interchangeability of biosimilars - video explainer